Institute

Back to overview
Name

Department for BioMedical Research Universität Bern

Address Department for BioMedical Research Universität Bern
Murtenstrasse 35
3010
CH-Bern
Show all

Projects

Responsible applicant Institution of higher education Start End date Funding scheme

The involvement of protein kinases in morhpogenic processes of adult mammary gland and testes
Ziemiecki Andrew University of Berne - BE 01.10.1998 30.09.2001 Project funding (Div. I-III)

The role of bone marrow adipocytes in the age-related development of chronic myeloid leukemia.
Amrein Michael University of Berne - BE 01.11.2013 31.10.2016 MD-PhD fellowships (funded by SNSF)

The role of antigen-specific and Toll-like receptor-dependent de novo generation of inducible regulatory T cells in the induction of intestinal immune homeostasis
Geuking Markus University of Berne - BE 01.10.2010 30.09.2013 Ambizione

Involvement of the EphB4 receptor tyrosine kinase in glandular and vascular integrity
Ziemiecki Andrew University of Berne - BE 01.10.2001 30.09.2002 Project funding (Div. I-III)

Involvement of the EphB4 receptor tyrosine kinase and its ligand ephrin-B2 in glandular and vascular integrity
Ziemiecki Andrew University of Berne - BE 01.10.2002 30.09.2005 Project funding (Div. I-III)

Endothelial Stem and Progenitor Cells: Optimized strategies to regenerate ischemic tissues in peripheral vascular disease
Kalka Christoph University of Berne - BE 01.10.2006 30.09.2009 Project funding (Div. I-III)

Somatic phVEGF-C gene therapy in patients with chronic critical limb ischaemia
Baumgartner Iris University of Berne - BE 01.04.1999 31.03.2001 NRP 37 Somatic Gene Therapy

Endothelial cell protection: The role of heparan sulfate proteoglycans and complement in pathophysiology and prevention of ischemia / reperfusion injury
Rieben Robert University of Berne - BE 01.04.2011 30.09.2014 Project funding (Div. I-III)

Aortic wall constitution in diabetes mellitus. A model to study protection of the abdominal aorta from aneurysmal degeneration
Diehm Nicolas University of Berne - BE 01.11.2008 30.04.2011 Project funding (Div. I-III)

Identification and mode of action of components from vegetable foodstuffs on bone metabolism
Mühlbauer Roman C. University of Berne - BE 01.10.1998 30.09.2001 Project funding (Div. I-III)

Installing a Hyperion CyTOF mass cytometry platform for high-dimensional single cell analysis at the University of Bern
Keogh-Stroka Deborah University of Berne - BE 01.10.2019 30.11.2021 R'EQUIP

Fast, accurate, and sensitive mass spectrometry for basic research in life sciences at the university of bern / mass spectrometer
Heller Manfred University of Berne - BE 01.10.2007 30.09.2008 R'EQUIP

Phytochemical and pharmacological study of two plants used in the treatment of malaria in Cameroon: Omphalocarpum elatum and Omphalocarpum procerum (Sapotaceae)
Lenta Ndjakou Bruno University of Berne - BE 01.08.2011 31.10.2011 International short research visits

Identification, mode of action and metabolism of plant componentsmodulating bone metabolism
Mühlbauer Roman C. University of Berne - BE 01.10.2001 30.09.2004 Project funding (Div. I-III)

Endothelial cell protection and attenuation of innate immunity in ischemia/reperfusion injury and organ transplantation
Rieben Robert University of Berne - BE 01.05.2007 30.04.2010 Project funding (Div. I-III)

Development and analysis of cell-based biodegradable scaffolds to repair myocardial defect
Tevaearai Hendrik University of Berne - BE 01.05.2005 30.04.2008 Project funding (Div. I-III)

Regulation od physiological apoptosis by a secreted Frizzled-re- lated protein: Interdiction of a Wnt:Frizzled signal responsible for survival?
Friis Robert Reaney University of Berne - BE 01.04.2001 31.05.2004 Project funding (Div. I-III)

Analyzing the oncogenic role of the hematopoietic transcription factor PU.1
Tschan Mario P. University of Berne - BE 01.10.2007 30.04.2010 Project funding (Div. I-III)

Advancement of functional genomics research at the University of Bern by extension of LC-MS platform
Heller Manfred University of Berne - BE 01.07.2012 30.06.2013 R'EQUIP

Direct measurements of capillary hemodynamics and perme- ability in human skin microcirculation.
Mahler Felix University of Berne - BE 01.07.1987 31.01.1991 Project funding (Div. I-III)

Treatment of established, chemically induced non-small cell lung cancer with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
Frese Steffen University of Berne - BE 01.10.2007 30.09.2008 Project funding (Div. I-III)

Identification and Characterization of Mechanisms Controlling Intracellular Glucocorticoid Concentrations.
Odermatt Alexander University of Berne - BE 01.05.2000 30.04.2003 Project funding (Div. I-III)

Disruption of Glucocorticoid- and Mineralocorticoid Receptor-Mediated Responses by Environmental Chemicals
Odermatt Alexander University of Berne - BE 01.01.2002 31.12.2006 NRP 50 Endocrine Disruptors

Direct measurement of capillary hemodynamics and permeability in human skin microcirculation
Mahler Felix University of Berne - BE 01.10.1980 30.09.1983 Project funding (Div. I-III)

Characterization of genes associated with programmed cell death in mammary gland, ovary and prostate
Friis Robert Reaney University of Berne - BE 01.06.1998 31.05.2001 Project funding (Div. I-III)

Prediction and Predictability of Resistance to Antibiotics: Studies Based on Coupled Map Lattices
Shiner John S. University of Berne - BE 01.07.2001 30.06.2004 NRP 49 Antibiotic resistance

Insufficient neovascularization in patients with peripheral arterial disease: Impaired up-regulation or failed synchronization of angiogenesis inducers?
Baumgartner Iris University of Berne - BE 01.05.2005 30.04.2007 Project funding (Div. I-III)

Identification and Characterization of Mechanisms Controlling Intracellular Glucocorticoid Concentrations.
Odermatt Alexander University of Berne - BE 01.05.2003 30.04.2006 Project funding (Div. I-III)

The Role of Endothelial Cells in Human Coronary Collateral Growth
Heller Manfred University of Berne - BE 01.05.2007 31.12.2010 Project funding (Div. I-III)

Complex involvement of the myeloid master gene PU.1 in cell proliferation and survival by inhibiting the p53 tumor suppressor pathway and by activating anti-apoptotic genes
Tschan Mario P. University of Berne - BE 01.04.2010 31.12.2012 Project funding (Div. I-III)
-